Bisphenol A Disrupts HNF4 alpha-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats

作者：Lam Hung Ming; Ho Shuk Mei; Chen Jing; Medvedovic Mario; Tam Neville Ngai Chung

来源：Endocrinology, 2016, 157(1): 207-219.

DOI：10.1210/en.2015-1363

Exposure of humans to bisphenol A (BPA) is widespread and continuous. The effects of protracted exposure to BPA on the adult prostate have not been studied. We subjected Noble rats to 32 weeks of BPA (low or high dose) or 17 beta-estradiol (E2) in conjunction with T replenishment. T treatment alone or untreated groups were used as controls. Circulating T levels were maintained within the physiological range in all treatment groups, whereas the levels of free BPA were elevated in the groups treated with T + low BPA (1.06 +/- 0.05 ng/mL, P < .05) and T + high BPA (10.37 +/- 0.43 ng/mL, P < .01) when compared with those in both controls (0.1 +/- 0.05 ng/mL). Prostatic hyperplasia, low-grade prostatic intraepithelial neoplasia (PIN), and marked infiltration of CD4+ and CD8+ T cells into the PIN epithelium (P < .05) were observed in the lateral prostates (LPs) of T + low/high BPA-treated rats. In contrast, only hyperplasia and high-grade PIN, but no aberrant immune responses, were found in the T + E2-treated LPs. Genome-wide transcriptome analysis in LPs identified differential changes between T + BPA vs T + E2 treatment. Expression of multiple genes in the regulatory network controlled by hepatocyte nuclear factor 4 alpha was perturbed by the T + BPA but not by the T + E2 exposure. Collectively these findings suggest that the adult rat prostate, under a physiologically relevant T environment, is susceptible to BPA-induced transcriptomic reprogramming, immune disruption, and aberrant growth dysregulation in a manner distinct from those caused by E2. They are more relevant to our recent report of higher urinary levels BPA found in patients with prostate cancer than those with benign disease.

• 出版日期2016-1